| Dr Piali Policarpio Dattaray, MD | |
|
3288 Moanalua Rd, Honolulu, HI 96819-1469 | |
| (808) 432-0000 | |
| Not Available |
| Full Name | Dr Piali Policarpio Dattaray |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 19 Years |
| Location | 3288 Moanalua Rd, Honolulu, Hawaii |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649469800 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | A98120 (California) | Secondary |
| 207Y00000X | Otolaryngology | MD-15779 (Hawaii) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hawaii Permanente Medical Group Inc | 7618880667 | 541 |
News Archive
A team of UCLA scientists has found that the pathogen that causes leprosy has a remarkable ability to avoid the human immune system by inhibiting the antimicrobial responses important to our defenses.
Researchers have discovered key details of how stroke or traumatic brain injury can trigger Alzheimer's disease (AD) by enhancing formation of brain-clogging amyloid plaques.
Some new strains of Covid-19 are not being picked up by standard PCR tests, reveals leading testing expert Dr Quinton Fivelman. He warns that new mutations mean some variants are not being picked up by the standard, widely-used, single gene tests.
Sequenom, Inc. today announced that the company's wholly-owned reference laboratory, the Sequenom Center for Molecular Medicine (Sequenom CMM), has authorized commencement of a pivotal clinical validation study. This validation study is designed to evaluate the clinical performance of the SensiGene T21 Laboratory Developed Test (LDT) for the detection of an overabundance in maternal blood of chromosome 21, which is associated with fetal chromosome 21 aneuploidy.
› Verified 7 days ago
| Entity Name | Hawaii Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710945969 PECOS PAC ID: 7618880667 Enrollment ID: O20031106000625 |
News Archive
A team of UCLA scientists has found that the pathogen that causes leprosy has a remarkable ability to avoid the human immune system by inhibiting the antimicrobial responses important to our defenses.
Researchers have discovered key details of how stroke or traumatic brain injury can trigger Alzheimer's disease (AD) by enhancing formation of brain-clogging amyloid plaques.
Some new strains of Covid-19 are not being picked up by standard PCR tests, reveals leading testing expert Dr Quinton Fivelman. He warns that new mutations mean some variants are not being picked up by the standard, widely-used, single gene tests.
Sequenom, Inc. today announced that the company's wholly-owned reference laboratory, the Sequenom Center for Molecular Medicine (Sequenom CMM), has authorized commencement of a pivotal clinical validation study. This validation study is designed to evaluate the clinical performance of the SensiGene T21 Laboratory Developed Test (LDT) for the detection of an overabundance in maternal blood of chromosome 21, which is associated with fetal chromosome 21 aneuploidy.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Piali Policarpio Dattaray, MD 3288 Moanalua Rd, Honolulu, HI 96819-1469 Ph: (808) 432-0000 | Dr Piali Policarpio Dattaray, MD 3288 Moanalua Rd, Honolulu, HI 96819-1469 Ph: (808) 432-0000 |
News Archive
A team of UCLA scientists has found that the pathogen that causes leprosy has a remarkable ability to avoid the human immune system by inhibiting the antimicrobial responses important to our defenses.
Researchers have discovered key details of how stroke or traumatic brain injury can trigger Alzheimer's disease (AD) by enhancing formation of brain-clogging amyloid plaques.
Some new strains of Covid-19 are not being picked up by standard PCR tests, reveals leading testing expert Dr Quinton Fivelman. He warns that new mutations mean some variants are not being picked up by the standard, widely-used, single gene tests.
Sequenom, Inc. today announced that the company's wholly-owned reference laboratory, the Sequenom Center for Molecular Medicine (Sequenom CMM), has authorized commencement of a pivotal clinical validation study. This validation study is designed to evaluate the clinical performance of the SensiGene T21 Laboratory Developed Test (LDT) for the detection of an overabundance in maternal blood of chromosome 21, which is associated with fetal chromosome 21 aneuploidy.
› Verified 7 days ago
Jae H. Lim, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
Dr. Eric Daniel Wirtz, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1 Jarrett White Road, Tripler Army Medical Center, Honolulu, HI 96859 Phone: 808-433-3181 | |
Dr. Kristi Adachi, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 1380 Lusitana St Ste 502, Honolulu, HI 96813 Phone: 808-533-0711 Fax: 808-538-6763 | |
Dr. Marcelo A Obando, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
Dr. John Jung Wan Cho, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 888 S King St, Honolulu, HI 96813 Phone: 808-522-4530 Fax: 808-522-4529 | |
Charissa N. L. K. Kahue, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
Dr. Patrick Joseph O'donnell, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1319 Punahou St Ste 1120, Honolulu, HI 96826 Phone: 808-983-6447 Fax: 808-983-8854 |